Skip to content
Atlas Research Compounds

Cortagen vs. Selank

A structured research comparison between Cortagen and Selank across compound identity, research category, evidence maturity, and interpretation boundaries.

Short peptide bioregulator

Cortagen

Proposed as a tissue-associated short peptide bioregulator; target-level evidence remains limited.

Evidence score1/5

Preclinical foundation

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Tuftsin-related neuropeptide

Selank

Investigated in neurochemical, stress-response, and immune-neural signaling models.

Evidence score2/5

Early human evidence

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Side-by-side research context

DimensionCortagenSelank
Catalog identityCortagen is mapped to short peptide bioregulator research.Selank is mapped to tuftsin-related neuropeptide research.
Research categoryCortagen is primarily organized around neural bioregulator models.Selank is primarily organized around stress-response and cognition research.
Interpretive boundaryUse the Cortagen profile and verified study pages before inferring mechanism or outcomes.Use the Selank profile and verified study pages before inferring mechanism or outcomes.

Combined literature starting points

Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.

  1. 01

    Short peptide bioregulator literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source
  2. 02

    Atlas internal research database

    Internal Research Database · 2026 · Database

    Open source
  3. 03

    Selank literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source